Back to PollNow

Back to companies

REPLIGEN CORP

RGENUSNASDAQPharmaceuticals & Healthcare

REPLIGEN CORP

Revenue

$738.3mn

YoY +16.4%

Operating income

$55.2mn

FY2025

Employees

—

Founded

—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API